SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimodLil Meyer-Arndt, Julian Braun, Florent Fauchere, Kanika Vanshylla, Lucie Loyal, Larissa Henze, Beate Kruse, Manuela Dingeldey, Karsten Jürchott, Maike Mangold, Ardit Maraj, Andre Braginets, Chotima Böttcher, Andreas Nitsche, Kathrin de la RosaSee the full list of authors
14 July 2022
Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysisMasoud Etemadifar, Hosein Nouri, Maristella Pitzalis, Maria Laura Idda, Mehri Salari, Mahshid Baratian, Sepide Mahdavi, Amir Parsa Abhari, Nahad Sedaghat
10 June 2022
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Melanie Korsen, Niklas Huntemann, Leoni Rolfes, Thomas Müntefering, Vera Dobelmann, Alexander M Hermann, Tristan Kölsche, Karin von Wnuck Lipinski, Christina B Schroeter, Christopher Nelke, Liesa Regner-Nelke, Jens Ingwersen, Marc Pawlitzki, Bianca TeegenSee the full list of authors
22 February 2022
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosisMassimiliano Di Filippo, Cinzia Cordioli, Simona Malucchi, Pietro Annovazzi, Paola Cavalla, Valentina Torri Clerici, Paolo Ragonese, Viviana Nociti, Marta Radaelli, Alice Laroni, Fabio Buttari, Lorena Lorefice, Diana Ferraro, Alberto Gajofatto, Luca ProsperiniSee the full list of authors
18 August 2021
Acute ischaemic stroke associated with SARS-CoV-2 infection in North AmericaAdam A Dmytriw, Mahmoud Dibas, Kevin Phan, Aslan Efendizade, Johanna Ospel, Clemens Schirmer, Fabio Settecase, Manraj K S Heran, Anna Luisa Kühn, Ajit S Puri, Bijoy K Menon, Sanjeev Sivakumar, Askan Mowla, Daniel Vela-Duarte, Italo LinfanteSee the full list of authors
25 January 2022
Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccinationChristina Crossette-Thambiah, Charis Pericleous, Namir Asmar, Joshua Bomsztyk, Amita Ranger, Abdul Shlebak, Saipriya Ramji, Soma Banerjee, Mike Laffan, Deepa J Arachchillage
29 September 2021
Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccineGuendalina Beatrice Bonifacio, Dharmini Patel, Sarah Cook, Elena Purcaru, Michael Couzins, Janine Domjan, Suzanne Ryan, Ahmad Alareed, Orla Tuohy, Sean Slaght, Julian Furby, David Allen, Haider A Katifi, Lucy Kinton
14 July 2021
Functional disorders after COVID-19 vaccine fuel vaccination hesitancyAlfonso Fasano, Antonio Daniele
18 August 2021
What should we do about vaccination of patients on anti-CD20 antibody therapy?Takayoshi Shimohata
2 August 2021
Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disordersCéline Louapre, Michella Ibrahim, Elisabeth Maillart, Basma Abdi, Caroline Papeix, Bruno Stankoff, Anne-Laure Dubessy, Caroline Bensa-Koscher, Alain Créange, Zina Chamekh, Catherine Lubetzki, Anne-Geneviève Marcelin, Jean-Christophe Corvol, Valérie Pourcher, See the full list of authors
2 August 2021
